News & Events zu Stellantis NV (STLA)STLAStellantis NV

Dow Rises 90.80 Points, Nasdaq Up 453.36 Points

The major averages were higher near noon as a rebound in heavyweight AI infrastructure stocks offset muted movement in broader sectors. The advance follows tech weakness last week, when underwhelming financial results from Anthropic and signs of debt stress among cloud providers, especially CoreWeave, dented demand for speculative positions in the sector.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Anthropic announced plans to commit 5% of its shares to a Public Benefit Fund to enable the company to "pursue our mission in new ways"SpaceXCEO Elon Musk pledged to give one of his SpaceX shares to "every kid in America," adding that "this will be the first of many."Investment bankers have been circling Blue Owl Capital, meeting with its founders to propose a full or partial sale of the business, WSJ saysMicrosofthas withdrawn from a UK data center deal with Nscale, Bloomberg saysCleveland-Cliffsshares are rising after the steel company reported Q3 results that beat expectations2. WALL STREET CALLS:Goldman Sachs upgraded CoreWeaveto BuyAmeriprisedouble downgraded to Underperform at BofA amid retention challengesIntelupgraded to Neutral at JPMorganLongbow downgraded Whirlpool, citing a weakening consumer backdropDatadogupgraded to Outperform at Bernstein3. AROUND THE WEB:Hon Hai Precisionwill pay $727M for a 50% stake in Mitsubishi Electric'sautomotive components unit, Bloomberg saysUberwon its bid to throw out two lawsuits in the UK valued at EUR 340M brought by London black cab drivers and two former private hire companies over allegations on how it obtained a private hire vehicle operating license, Reuters reportsStellantisCEO Ned Curic said the company plans to continue hiring more engineers as the company rolls out new models as part of its turnaround plan, Bloomberg saysMorgan Stanleyhas entered a partnership with Raisin UK, a fintech platform, to provide savings accounts to individuals in the country, Bloomberg reportsQuantinuumsaid it has achieved record-setting results to correct the tendency for "qubits" at the center of a quantum computer to generate errors based on tiny disturbances in their environments, WSJ reports4. MOVERS:Silence Therapeuticsgains in New York after entering an agreement to be acquired by Merck KgaAfor $20 per ADS in cashDisc Medicineincreases after reporting its APOLLO trial of bitopertin met all its primary and secondary endpointsStrivehigher after announcing it purchased 4,045 bitcoinFervo Energylower after JPMorgan removed it from its Analyst Focus ListDynex Capitalfalls after reporting quarterly results5. EARNINGS/GUIDANCE:Nyxoahreported preliminary Q3 results and cut its guidance for FY26Cleveland-Cliffsreported Q3 results, with EPS beating consensusFifth Thirdreported Q3 results and provided guidance for Q4Eos Energyprovided guidance for Q3 and backed its outlook for FY26EquipmentShareraised its outlook for FY26INDEXES:Near midday, the Dow was up 90.80, or 0.17%, to 52,093.21, the Nasdaq was up 453.36, or 1.73%, to 26,593.40, and the S&P 500 was up 66.01, or 0.86%, to 7,725.45.

Stellantis Estimates Q3 Shipments at 1.3M Units

Stellantis released its estimated consolidated shipments for Q3. The term "shipments" describes the volume of vehicles delivered to dealers, distributors, or directly from the company to retail and fleet customers, which generally drive revenue recognition. Consolidated shipments for the three months ended September 30, were an estimated 1.3M units, down 1% year-over-year. BEV growth in Enlarged Europe was offset by lower volumes in North America, reflecting the planned summer production shutdown, and in Middle East & Africa, mainly due to a drop in the Turkish market.

EU Sets 350,000 Annual Import Limit on Chinese Hybrid Vehicles

Catch up on the weekend's top five stories with this list compiled by The Fly: 1) The European Union will instill a 350,000-car limit per year for imports of Chinese hybrid vehicles, with the measure taking effect as soon as December 1, Alberto Nardelli and Jorge Valero of Bloomberg reports, citing a document outlining the plan seen by the journal. The cap will increase annually by 6% starting the second year of application. The cap will apply to all imports of hybrids. Publicly traded companies in the space include BYD (BYDDY), Geely (GELYF), Honda (HMC), Mercedes-Benz (MBGYY), Nissan (NSANY), Stellantis (STLA), Toyota (TM) and Volkswagen (VWAGY). 2) Amazon (AMZN) is in discussions to acquire Decart, an AI startup, in a deal that may be valued around $7B, Kate Clark and Lauren Thomas of The Wall Street Journal reports, citing people familiar with the matter. A deal could come soon if talks don't fall apart or another suitor doesn't emerge, the sources added. 3) Pennsylvania Governor Josh Shapiro and Department of Community and Economic Development, DCED, Secretary Rick Siger announced the Commonwealth has secured an over $800M investment from global biopharma company GSK (GSK) to expand its operations in Montgomery County. The expansion will create more than 300 new jobs over the next five years, retain approximately 4,500 existing full-time jobs across the Commonwealth, and continue growing Pennsylvania's life sciences industry. GSK is expanding its facilities in Upper Merion Township, with construction planned to begin in 2027. 4) Nvidia (NVDA) is in discussions to either acquire or increase its investment in Reflection AI, a US start-up, George Hammond, Michael Acton, George Steer, and Arash Massoudi of The Financial Times reports, citing people with direct knowledge of the matter. Discussions are currently in the early stages, and a deal could take different forms, the sources added. 5) AstraZeneca (AZN) announced results from the HICKORY Phase III trial showed that efzimfotase alfa, ALXN1850, did not achieve statistical significance but demonstrated a numerical improvement in the primary endpoint of Six-Minute Walk Test in adolescents and adults with hypophosphatasia, HPP, who had not been previously treated with Strensiq at week 25, compared to placebo. In the overall population, at week 25, efzimfotase alfa achieved a least squares mean difference of 17.05 metres change from baseline in the primary endpoint of 6MWT, compared to placebo.